| 摘要 |
<p>The present invention relates to use of bis-acid(5-androsten-17-one-3β-hydroxyl) (I) diesters for manufacture of pharmaceuticals for treatment of arrhythmia, myocardial ischemia, brain ischemia, hypoimmunity, osteoporosis and renal failure.</p> |
